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Purpose: To identify the gene mutations causing X-linked infantile nystagmus in two Chinese families (NYS003 and
NYS008), of which the NYS003 family was assigned to the FERM domain–containing 7 (FRMD7) gene linked region
in our previous study, and no mutations were found by direct sequencing.
Methods: Two microsatellites, DXS1047 and DXS1001, were amplified using a PCR reaction for the linkage study in
the  NYS008  family.  FRMD7  was  sequenced  and  mutations  were  analyzed.  Multiplex  ligation-dependent  probe
amplification (MLPA) was used to detect FRMD7 mutations in the NYS003 family.
Results: The NYS008 family yielded a maximum logarithm of odds (LOD) score of 1.91 at θ=0 with DXS1001.
FRMD7 sequencing showed a nucleotide change of c. 623A>G in exon7 of the patients’ FRMD7 gene, which was predicted
to result in an H208R amino acid change. This novel mutation was absent in 100 normal Han Chinese controls. No
FRMD7 gene mutations were detected by MLPA in the NYS003 family.
Conclusions: We identified a novel mutation, c. 623A>G (p. H208R), in a Han Chinese family with infantile nystagmus.
This mutation expands the mutation spectrum of FRMD7 and contributes to the research on the molecular pathogenesis
of FRMD7.
Infantile nystagmus (IN), also referred to as congenital
nystagmus  (CN),  congenital  “motor”  nystagmus  (CMN),
idiopathic  congenital  nystagmus  (ICN),  or  congenital
idiopathic nystagmus (CIN), is a relatively common ocular
motor disorder characterized by rapid to-and-fro oscillations
of the eyes. It usually presents at birth or develops within the
first few months of life, and it is different from “sensory defect
nystagmus” caused by inherited ocular diseases, including:
albinism,  achromatopsia,  Leber  congenital  amaurosis,
congenital cataract, and anterior segment dysgenesis [1,2].
The etiology of infantile nystagmus is unclear.
IN may be inherited as an autosomal dominant, autosomal
recessive, or X-linked trait, while the X-linked inheritance is
believed to be the most common mode [3]. Two IN loci have
been mapped on chromosome Xp11.4-p11.3 [4] and Xq26-
q27 [5], respectively, of which the FERM domain–containing
7 gene (FRMD7) was identified to be on the chromosome
Xq26-q27 region [6], but no responsible genes have been
cloned yet from the Xp11.4-p11.3 region.
FRMD7  is  a  newly  identified  member  of  the  FERM
family (F for 4.1 protein, E for ezrin, R for radixin and M for
moesin), and consists of 12 exons spanning approximately 51
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kb on chromosome Xq26-q27. FRMD7 encodes 714 residues
and is expressed in the ventricular layer of the forebrain,
midbrain,  cerebellar  primordium,  spinal  cord,  and  the
developing neural retina in embryos 56 day post-ovulation. It
is restrictively expressed in the mid- and hindbrain (where the
center of the eye’s movement is located) in earlier embryos
37  day  post-ovulation  [6].  The  FRMD7  protein  has  B41,
FERM-N, FERM-M, FERM-C, and FA structural domains
with  the  conserved  domains  concentrated  at  the  B41  and
FERM-C domains (Figure 1). In fact, the FERM domain is
the same as the B41 domain since it was originally identified
in band 4.1 (also known as protein 4.1) [7]. The B41 domain
is located between residues 1–192, and the FERM-C domain
is located between residues 186–279. The FRMD7 protein has
close  homology  to  two  other  FERM  domain  containing
proteins: RhoGEF and pleckstrin domain protein 1 (FARP1;
NM_005766) and FARP2 (NM_014808). FARP1 is known
to  promote  the  dendritic  growth  of  spinal  motor  neuron
subtypes,  while  FARP2  has  been  shown  to  modulate  the
length and degree of neurite branching in developing cortical
neurons.
We  previously  reported  five  mutations  in  FRMD7  in
seven Chinese families with infantile idiopathic nystagmus
[8].  However,  no  mutations  were  identified  by  directly
sequencing FRMD7 in the NYS003 family (one of the seven
reported families assigned to the FRMD7 gene linked region).
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461In this study, we tried to detect FRMD7 mutations in the
NYS003 family by using multiplex ligation-dependent probe
amplification (MLPA). We also attempted to identify gene
mutations in the other Han Chinese family (NYS008) with
infantile nystagmus.
METHODS
Patient  ascertainment:  Two  IN  families  (NYS003  and
NYS008)  were  recruited  for  this  study  (Figure  2).  All
participants  underwent  an  ophthalmologic  examination,
including  visual  acuities,  slit  examination  of  the  lens,
examination  of  the  vitreous,  fundus,  electroretinograms
(ERGs), and visual evoked potentials (VEP) as well. Eye
movements  were  recorded  with  the  Eye  Tracker  system
(Eyelink 2000; SR Research, Kanata, Ontario, Canada). After
informed consent was obtained, blood samples were collected
from the affected and unaffected members in the two IN
families.  DNA  was  extracted  from  blood  lymphocytes
according to the standard protocol (Roche Biochemical, Inc.,
Shanghai,  China).  Briefly,  the  white  blood  cells  were
separated from whole blood via a preferential red blood cell
lysis and then lysed by a strong anionic detergent. After the
proteins were removed by dehydration and precipitation, the
purified  DNA  is  subsequently  recovered  via  ethanol
precipitation.  This  study  obtained  IRB  approval  from  the
Tianjin  Eye  Hospital,  Tianjin,  China,  and  was  conducted
according to the declaration of Helsinki’s tenets.
Genotyping and linkage analysis: A linkage analysis was
performed  with  two  fluorescently  labeled  microsatellite
markers, DXS1001 and DXS1047, after PCR amplification in
a 10 μl reaction mixture containing 50 ng of genomic DNA,
1× PCR buffer, 2.0 mM MgCl2, 0.2 mmol/l of each dNTP, 5
pmol/l of each forward and reverse primer, and 0.2 U of Ampli
Taq Gold DNA polymerase (Applied Biosystems, Foster city,
CA). The PCR products from each DNA sample were pooled
and mixed with a loading cocktail containing HD-400 size
standards  (PE  Applied  Biosystems,  Foster  City,  CA)  and
loading dye. The resulting PCR products were separated on
an ABI3130 sequencer, and analyzed with GENEMAPPER
3.7 (PE Applied Biosystems).
Two-point  logarithm  of  odds  (LOD)  scores  were
calculated  with  easyLinkage  plus  v4.0  beta  software,
assuming an X-linked dominant trait with an affected allele
frequency of 0.001. The marker order and distance between
DXS1001 and DXS1047 were obtained from the National
Center for Biotechnology Information (NCBI).
Mutation analysis: Mutation screening of FRMD7 in family
NYS008  was  conducted  using  a  direct  DNA  sequence
analysis. Individual exons of FRMD7 were amplified by PCR
as previously described [8]. Briefly, whole coding regions and
exon-intron boundaries of FRMD7 were PCR-amplified in 50
μl of standard PCR buffer containing 1.5 mmol/l MgCl2, 0.2
mmol/l of each dNTP, 0.5 μmol/l of each primer (Table 1), 1
U of Taq polymerase , and 50 ng of DNA. The amplification
program was an initial 2 min denaturation at 98 °C, followed
by 30 cycles of 30 s at 94 °C, 30 s at 55 °C, 1 min at 72 °C,
and a final 7 min extension step at 72 °C. The PCR products
were  extracted  using  the  QIAquick  Gel  Extraction  Kit
(Qiagen,  Valencia,  CA).  DNA  sequencing  analysis  was
performed with the BigDye Terminator Cycle Sequencing
V3.1  Kit  on  an  ABI  PRISM  3130  Genetic  Analyzer  (PE
Applied Biosystems). Sequencing results were assembled and
analyzed  with  DNASTAR  software’s  Seqman  program
(DNASTAR  Inc.,  Madison,  WI).  A  multiple  sequence
Figure 1. Graphical structure of the FRMD7 domains.
TABLE 1. PRIMERS USED TO AMPLIFY THE INDIVIDUAL EXONS OF FRMD7.
Exon Forward primer Reverse primer Tm (°C) Product length (bp)
1 AGGAGACTGCCCAGATGCTA GGGCTGTTCACAAATGACAA 60 348
2 GAAACAGGGCTTGCAGAGAG GCAATGCTAGACACAAAGAACC 60 246
3 TGCTCAATGCCATGCTCTAC AAAGCCCTTTTCTCCCCTTA 58 199
4 TGGGTGTGTGTGTGTGTGTG GCCCCCAATAAATGGAGAAT 58 237
5 TGGATCTGGGAGAAGGAAAA GCTCCTGTGCTTGGTTCTCT 60 238
6 GAGGACAAGGGTATGCTGGA TCAGGTTTAAGGGCTTGCTC 58 281
7 GAGCTCTCAGGGTGGAAATG ACACCCAAGTTTGAGCCAAG 58 293
8 TGCACTGTCTTACAAGCCAACT CGATTTGCAGAAACAACCAA 56 231
9 TTGGGATTTGAAGGTCTTTGA TCCTCCTAAGCCTCCTGTGTT 60 300
10-11 AGCCTATTGGTTTATGGCTAGAAC GCAGAATCAATTCATGGAAGC 56 393
12a GGCCTTTTCCTTCTTTCACC CTGGGGAGGCATAATACCAA 58 472
12b AGCTCCTTCCAAACAAGCTG TGACTGAGAGCAGGACAAGG 60 524
12c GCGGTAGGAGCAACATCAAT CCAAGAAAATGGTTTCTACAACTTC 58 560
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462alignment was performed using the Clustal W algorithm in the
software package. The modeled structures were built with
SWISS-MODEL.
Multiplex ligation-dependent probe amplification (MLPA):
MLPA was conducted by using the supplied protocol from the
SALSA  P269  FRMD7-NYS1  probe  kit  of  MRC-Holland
(Amsterdam, Holland), which contains 28 MLPA probes with
amplification  products  between  166  and  391  nucleotides.
One-hundred ng of DNA (5 μl) was denatured at 98 °C for 5
min, and then was mixed with the probe set and MLPA buffer
after cooling at 25 °C. The mixture was re-heated to 95 °C,
and then was incubated for 16 h at 60 °C. Following probe
hybridization, the DNA ligase and ligation buffer were added,
and the ligation was proceeded for 15 min at 54 °C. One
microliter  of  ligation  products  were  amplified  by  PCR
according to the manufacturer’s protocol. The PCR products
were then mixed with a loading cocktail containing HD-400
size  standards  (PE  Applied  Biosystems)  and  de-ionized
Figure 2. Two Chinese families with X-linked infantile nystagmus. The squares represent the males, the circles represent females, the shaded
symbols signify the affected individuals, the dotted circles represent the female carriers, a diagonal line through a symbol indicates a deceased
family member, and the arrow indicates the proband.
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463formamide. The resulting PCR products were separated on an
ABI3130 sequencer, and analyzed with GENEMAPPER 3.7
(PE Applied Biosystems). Specific peaks corresponding to
each  exon  were  identified  according  to  their  migration
(relative  to  the  size  standards),  and  were  exported  to  a
Microsoft  Excel  (Microsoft  Corporation,  Redmond,  WA)
spreadsheet. Peak heights of each fragment were compared to
a control sample to obtain a dosage quotient (DQ) representing
the gene dosage of each amplicon. For normal sequences, a
dosage quotient of 1.0 is expected; if a deletion or duplication
is  present,  the  dosage  quotient  should  be  0.7  and  1.3,
respectively.
RESULTS
The NYS008 family from Hebei province, China, included 4
affected males and 4 female carriers. Individual IV3 was a
proband in this family. His parents were consanguineously
married (Figure 2A). He developed nystagmus at the age of 3
Figure 3. Eye movement recording of the proband in the NYS008
family. Eye movement recordings of the primary gaze of the right
and left eyes of the proband showed horizontal nystagmus (A and
B). The ocular oscillation could be dampened at neither the left (C)
nor the right (D) gaze of 10°, but could be achieved at a viewing
distance of 33 cm (E). The vertical component of the eye movement
is denoted in green, and the horizontal movement is shown in red.
to 4 months, and had a horizontal jerk ocular oscillation at a
distance, with the best-corrected visual acuity of 0.5 in both
eyes at the age of 32. His eye movement recordings in a
primary gaze of the right and left eyes showed horizontal
nystagmus with slow rightward drift and fast beats to the left
(Figure  3).  The  ocular  oscillation  could  be  dampened  at
neither a left nor a right gaze of 10°, but could be achieved at
a viewing distance of 33 cm (Figure 3). Other male patients
in this family had various reduced visual acuity, ranging from
0.2 to 1.0 with a horizontal jerk ocular oscillation. None of the
patients in this family had a compensatory face turn.
Figure  4.  Identification  of  the  623A>G  (p.  H208R)  in  FRMD7.
Sequencing  chromatograms  from  a  normal  individual  (top),  an
affected male (middle), and a female carrier (bottom), showing an
A→G change in exon 7.
Figure 5. Alignment of FRMD7 amino acids. The alignment of amino
acids  around  p.H208  (denoted  by  the  black  arrow)  of  FRMD7
revealed evolutionary conservation of the Histidine among Homo
sapiens,  Pongo  abelii,  Rattus  norvegicus,  Mus  musculus,  Canis
familiaris, Gallus gallus, Xenopus lavis, and Danio rerio.
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464A linkage study showed that the maximum LOD score of
1.91 was yielded at the polymorphic marker DXS1001 (θ=0),
and a positive LOD score of 1.31 was achieved at DXS1047.
Sequencing of FRMD7 illustrated a single nucleotide change
of c.623A>G in exon 7, which was predicted to result in a wild
type amino acid of Histidine (H) substituted by a mutant type
amino acid of Arginine (R) at codon 208 (Figure 4). This
nucleotide change was absent in 100 normal controls after
sequencing of FRMD7. The multiple sequence alignment of
the  FRMD7  protein  indicated  that  H208R  was  conserved
among Homo sapiens, Pongo abelii, Rattus norvegicus, Mus
musculus, Canis familiaris, Gallus gallus, Xenopus lavis, and
Danio  rerio  (Figure  5).  A  Position-Specific  Independent
Counts  (PISC)  score  of  2.53  was  yielded  after  using  the
POLYPHEN program to predict the functional and structural
changes of the amino acid substitution. The modeled protein
structure assessed by the ANOLEA program [9] would thus
be unstable if the Histidine at codon 208 was substituted by
the Arginine (Figure 6).
The NYS003 family reported in our previous study (the
C family from the Liaoning province, China [8]), consisted of
6 male patients and 9 female carriers (Figure 2B). The results
analyzed by MLPA using 28 probes on the patients are listed
in Table 2, and the average dosage quotient (DQ) at each probe
ranged from 0.8 to 1.1, which suggested that mutations were
not detected by the MLPA method.
DISCUSSION
To  date,  40  mutations  in  FRMD7  have  been  reported
worldwide in families with X-linked congenital nystagmus
from  various  ethnic  backgrounds  [6,8,10-16].  These
mutations  include  missense,  nonsense,  and  splicing
mutations, as well as insertions and deletions according to the
Human Gene Mutations Database. However, the underlying
molecular mechanisms of these mutations in CIN are still not
fully  understood.  FRMD7  may  play  an  important  role  in
neuronal development, particularly in brain regions that are
associated with ocular motor control [17-20]. It may also be
involved in signal transduction between the plasma membrane
and cytoskeleton because it contains a FERM domain at the
NH2-terminus [21].
In this study, we found a novel nucleotide change of c.
623A>G in exon7 of the FRMD7 gene in the NYS008 family,
but  we  were  unable  to  detect  FRMD7  mutations  in  the
NYS003 family. The heterozygote change of c.623A>G in
FRMD7 in the NYS008 family should be regarded as a novel
gene mutation rather than a polymorphism nucleotide change
due to the following reasons: 1) It is absent in 100 normal
controls. 2) We predict that the c.623A>G change would result
in a Histidine to Arginine change at codon 208 where it is
located within highly conserved regions that are invariant in
Homo  sapiens,  Pongo  abelii,  Rattus  norvegicus,  Mus
musculus, Canis familiaris, Gallus gallus, Xenopus lavis, and
Danio rerio. This suggests that the Histidine at codon 208 is
critical to the protein’s normal functioning. 3) A PISC score
Figure 6. The 3D model and the anolea mean force potential plot for the target protein of human FRMD7. A: The model rendered in 3-D for
the target human FRMD7 protein. α-helices, coils, and β-sheets are depicted in red, gray, and green, respectively. Only two amino acids, H208
and M209, are located inside the region between the two β-sheets (denoted by an arrow). B: The anolea mean force potential plot for the target
protein of the human FRMD7. Above is the mutant type of the FRMD7 protein; below is the wild type of the FRMD7 protein. The y-axis of
the plot represents the energy for each amino acid of the protein chain. Negative energy values (in green) represent a favorable energy
environment, whereas positive values (in red) indicate an unfavorable energy environment for a given amino acid. A favorable energy
environment tends to be damaged because of an H to R change at codon208.
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465of  2.53  predicted  by  POLYPHEN  suggests  that  the
substitution of Histidine to Arginine at codon 208 would most
likely  damage  the  protein  structure  and/or  the  protein
function.
Further analysis of the FRMD7 protein structure in the
model shows that the Histidine at codon 208 is one of two
amino acids located inside the region between the two β-
sheets, and substituting it with Arginine is likely to destabilize
the protein by introducing a larger amino acid within restricted
areas  of  the  protein.  This  has  been  demonstrated  by  the
ANOLEA  program,  which  found  that  a  favorable  energy
environment tends to be damaged by amino acid substitutions
in that region (Figure 6).
It has been reported that nearly all missense mutations,
except for G296R, Y301C, and S340L, occurred in the B41
and the FERM-C domains of FRMD7 [6,12]. H208R occurred
in the FERM-C domain which seems to be a mutation-rich
region [22], and was close to two other known mutations
(Q201X and N221D [6]) in the same domain.
The NYS003 family’s responsible gene was previously
localized to the region linked with the microsatellite marker
DXS1047 (Zmax=2.42, θmax=0.1). No mutations were detected
in FRMD7 by direct sequencing, although all coding regions
and exon-intron boundaries were sequenced [8]. The method
of  direct  sequencing  based  on  a  single  exon's  PCR
amplification from genomic DNA has several shortcomings
in detecting most exon deletions and duplications [23]. MLPA
is believed to be a robust assay that offers several advantages
for  gene  mutation  detection,  particularly  for  detecting
deletions/duplications of one or more exons in the gene [23,
24]. It is a variation of the PCR reaction that permits multiple
targets to be amplified with only a single primer pair [23].
Each  MLPA  probe  consists  of  two  halves  of  the
oligonucleotides which recognize adjacent target sites on the
DNA and can be ligated into a complete probe when both of
them  are  hybridized  to  their  respective  targets.  Only  the
ligated oligonucleotides can be amplified, not the unbound
probe oligonucleotides. Each complete probe has a unique
TABLE 2. FRMD7 GENE DOSAGE ANALYSIS BY MLPA IN THE NYS003 FAMILY.
Probe Average DQ SD dosage
PDCD8 0.9 0.09 Normal
FRMD7 exon1 1.07 0.07 Normal
FRMD7 exon1 0.93 0.08 Normal
FRMD7 exon2 0.81 0.15 Normal
FRMD7 exon2 0.88 0.09 Normal
FRMD7 exon4 0.97 0.07 Normal
FRMD7 exon4 0.83 0.04 Normal
FRMD7 exon5 0.86 0.07 Normal
FRMD7 exon6 0.98 0.08 Normal
FRMD7 exon7 0.98 0.07 Normal
FRMD7 exon8 0.94 0.07 Normal
FRMD7 exon9 0.91 0.08 Normal
FRMD7 exon9 0.98 0.05 Normal
FRMD7 exon11 1.02 0.03 Normal
FRMD7 exon12 1.01 0.05 Normal
FRMD7 exon12 1.03 0.06 Normal
GPC4 0.99 0.08 Normal
GPC3 1.01 0.08 Normal
Control 0.96 0.11 Normal
Control 1.03 0.08 Normal
Control 1.02 0.04 Normal
Control 1.03 0.07 Normal
Control 0.94 0.08 Normal
Control 0.93 0.06 Normal
Control 1.04 0.08 Normal
Control 1.02 0.07 Normal
Control 0.95 0.07 Normal
Control 1.09 0.06 Normal
        For normal sequences, a dosage quotient (DQ) of 1.0 is expected; if a deletion or duplication is present, the dosage quotient
        should be 0.7 and 1.3, respectively.
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466length so that its resulting amplicons can be separated and
identified by electrophoresis. By comparing the peak pattern
obtained on a given sample with that obtained on various
reference samples, the relative quantity of each amplicon can
be  determined.  Because  the  amount  of  ligated  probes  is
dependent on the number of specific primer binding sites, this
method is suitable for the detection of chromosomal deletions
or duplications.
To  exclude  the  possibility  of  FRMD7  gene
rearrangements in the NYS003 family, the MLPA method was
used  in  this  study.  However,  we  have  not  yet  identified
FRMD7 mutations in this family. The fact that we detected no
mutations from either direct sequencing or MLPA, illustrated
that our experiments’ mutation screening techniques might be
limited in their ability to detect unknown regions (e.g., the
promoter or other regulatory regions including those within
introns) in FRMD7. Further study on the patients’ RNA might
find mutations in the unknown regions in FRMD7.
Recently, investigations of the molecular pathogenesis to
some  ocular  movement  diseases  develop  very  quickly,
especially to a group of the congenital cranial dysinnervation
disorders  (CCDDs),  including  congenital  fibrosis  of  the
extraocular muscles (CFEOM), Duane’s retraction syndrome
(DRS), and horizontal gaze palsy with progressive scoliosis
(HGPPS)  and  MÖbius  syndrome  [25].  Some  responsible
genes for CCDDs (kinesin family member 21A [KIF21A] for
CFEOM1  [26],  paired-like  homeobox  2a  [ARIX]  for
CFEOM2 [27], roundabout, axon guidance receptor, homolog
3 [Robo3] for HGPPS [28], and chimerin 1 [CHN1] for DRS
[29]) have been identified and are believed to be involved
either in the development of brainstem motor nuclei or in axon
guidance. Some advanced neuroimaging techniques, such as
diffusion  tensor  imaging  (DTI)  and  diffusion  spectrum
imaging  (DSI)  [30],  have  also  been  used  to  accurately
recognize new patterns of aberrant axon connectivity and
phenotypically confirm the findings in genetic studies. The
combination  of  advanced  neuroimaging  techniques  and
genetic studies is likely to advance our understanding of the
molecular mechanisms of congential nystagmus.
In summary, we investigated the gene mutations in two
Chinese families with infantile nystagmus and identified a
novel gene mutation, c. 623A>G (p. H208R), in FRMD7 in
one of the families. This mutation will expand the mutation
spectrum  of  FRMD7  and  contribute  to  the  study  of  the
FRMD7 gene’s molecular pathogenesis.
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